Skip to content

The effect of Bromocriptine rebound method on Intracytoplasmic sperm injection cycles outcome

a randomized clinical trial to compare the effect of bromocriptine-rebound method on ongoing pregnancy and live birth after Intracytoplasmic sperm injection cycles with long protocol

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105016345N1
Enrollment
114
Registered
2011-06-22
Start date
2009-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF/ICSI. In vitro fertilization

Interventions

Intervention 1: intervention : similar to long protocol except administration of Bromocriptine 2.5 mg per day since day 4 of follicular phase till 7 days before gonadotropine syimulation. Interventio
Treatment - Drugs
intervention : similar to long protocol except administration of Bromocriptine 2.5 mg per day since day 4 of follicular phase till 7 days before gonadotropine syimulation
control : long protocol In preceding cycle, OCP was administered from day 3 for a month and Buserelin (Superfact, Aventis, Frankfurt, Germany) was started 0.5 mg daily from day 21. Then, ovar

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : normal endocrine pattern ; age younger than 40 yr ; normal basic serum prolactine concentrations ; ovulatory cycles ; Exclusion criteria : severe male factor as a cause of infertility according to the WHO criteria

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fertilized oocyte. Timepoint: 1 months after intervention. Method of measurement: embryology labratory.

Secondary

MeasureTime frame
Ongoing pregnancy & Live birth. Timepoint: 16 weeks & 37 weeks. Method of measurement: prenatal visits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRamak Esmaeeli Azad

Tehran University of Medical Science

ramak.esmaeiliazad@yahoo.com+98 21 8800 0085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026